Your browser doesn't support javascript.
loading
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic.
Sud, A; Jones, M E; Broggio, J; Loveday, C; Torr, B; Garrett, A; Nicol, D L; Jhanji, S; Boyce, S A; Gronthoud, F; Ward, P; Handy, J M; Yousaf, N; Larkin, J; Suh, Y-E; Scott, S; Pharoah, P D P; Swanton, C; Abbosh, C; Williams, M; Lyratzopoulos, G; Houlston, R; Turnbull, C.
Afiliação
  • Sud A; Division of Genetics and Epidemiology, Institute of Cancer Research, London.
  • Jones ME; Division of Genetics and Epidemiology, Institute of Cancer Research, London.
  • Broggio J; National Cancer Registration and Analysis Service, Public Health England, Wellington House, London.
  • Loveday C; Division of Genetics and Epidemiology, Institute of Cancer Research, London.
  • Torr B; Division of Genetics and Epidemiology, Institute of Cancer Research, London.
  • Garrett A; Division of Genetics and Epidemiology, Institute of Cancer Research, London.
  • Nicol DL; Urology Unit, Royal Marsden NHS Foundation Trust, London.
  • Jhanji S; Department of Anaesthesia, Perioperative Medicine and Critical Care, Royal Marsden NHS Foundation Trust, London; Division of Cancer Biology, Institute of Cancer Research, London.
  • Boyce SA; Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford.
  • Gronthoud F; Department of Microbiology, Royal Marsden NHS Foundation Trust, London.
  • Ward P; Department of Anaesthesia, Perioperative Medicine and Critical Care, Royal Marsden NHS Foundation Trust, London.
  • Handy JM; Department of Anaesthesia, Perioperative Medicine and Critical Care, Royal Marsden NHS Foundation Trust, London.
  • Yousaf N; Lung Cancer Unit.
  • Larkin J; Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London; Division of Clinical Studies, Institute of Cancer Research, London.
  • Suh YE; Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, London.
  • Scott S; RM Partners, West London Cancer Alliance, Royal Marsden NHS Foundation Trust, London.
  • Pharoah PDP; Department of Public Health and Primary Care, University of Cambridge, Cambridge.
  • Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London.
  • Abbosh C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London; Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London.
  • Williams M; Department of Clinical Oncology, Imperial College Healthcare NHS Trust, London; Computational Oncology Group, Imperial College London, London.
  • Lyratzopoulos G; National Cancer Registration and Analysis Service, Public Health England, Wellington House, London; Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group, University College London, London.
  • Houlston R; Division of Genetics and Epidemiology, Institute of Cancer Research, London; Department of Clinical Genetics, Royal Marsden NHS Foundation Trust, London, UK.
  • Turnbull C; Division of Genetics and Epidemiology, Institute of Cancer Research, London; National Cancer Registration and Analysis Service, Public Health England, Wellington House, London; Department of Clinical Genetics, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: clare.turnbull@icr.ac.
Ann Oncol ; 31(8): 1065-1074, 2020 08.
Article em En | MEDLINE | ID: mdl-32442581

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Pandemias / Tempo para o Tratamento / Betacoronavirus / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Pandemias / Tempo para o Tratamento / Betacoronavirus / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article